Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/2098
Title: Treatment limitations and clinical outcomes in critically ill frail patients with and without COVID-19 pneumonitis.
Author: Subramaniam, A.
Tiruvoipati, R.
Pilcer, David
Bailey, Michael
Issue Date: 2022
Publication Title: Journal of the American Geriatrics Society
Volume: 71
Issue: 1
Start Page: 145
End Page: 156
Abstract: Background The presence of treatment limitations in patients with frailty at intensive care unit (ICU) admission is unknown. We aimed to evaluate the presence and predictors of treatment limitations in patients with and without COVID-19 pneumonitis in those admitted to Australian and New Zealand ICUs. Methods This registry-based multicenter, retrospective cohort study included all frail adults (≥16 years) with documented clinical frailty scale (CFS) scores, admitted to ICUs with admission diagnostic codes for viral pneumonia or acute respiratory distress syndrome (ARDS) over 2 years between January 01, 2020 and December 31, 2021. Frail patients (CFS ≥5) coded as having viral pneumonitis or ARDS due to COVID-19 were compared to those with other causes of viral pneumonitis or ARDS for documented treatment limitations. Results 884 frail patients were included in the final analysis from 129 public and private ICUs. 369 patients (41.7%) had confirmed COVID-19. There were more male patients in COVID-19 (55.3% vs 47.0%; p = 0.015). There were no differences in age or APACHE-III scores between the two groups. Overall, 36.0% (318/884) had treatment limitations, but similar between the two groups (35.8% [132/369] vs 36.1% [186/515]; p = 0.92). After adjusting for confounders, increasing frailty (OR = 1.72; 95%-CI 1.39–2.14), age (OR = 1.05; 95%-CI 1.04–1.06), and presence of chronic respiratory condition (OR = 1.58; 95%-CI 1.10–2.27) increased the likelihood of instituting treatment limitations. However, the presence of COVID-19 by itself did not influence treatment limitations (odds ratio [OR] = 1.39; 95%-CI 0.98–1.96). Conclusions The proportion of treatment limitations was similar in patients with frailty with or without COVID-19 pneumonitis at ICU admission.
Description: Includes data from WHCG
URI: http://hdl.handle.net/11054/2098
DOI: https://doi.org/10.1111/jgs.18044
Internal ID Number: 02080
Health Subject: COVID-19
INTENSIVE CARE
PANDEMIC
TREATMENT LIMITATIONS
VIRAL PNEUMONIA
Type: Journal Article
Article
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.